Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan

Showing results (321-330 of 382) with videos related to

Pageof 39
Sort By:
Journal of the American Heart Association|April 25, 2020
Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor InitiationJennifer A Rymer, Katherine E Mues, Keri L Monda, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2018
Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United StatesAnne M Butler, Karynsa Cetin, Rohini K Hernandez, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Leveraging School Infection Data to Address Community COVID-19 Data GapsEba Moreda, Hedille Al-Dhalimy, Mary Ha, et al.
Archives of Internal Medicine|April 25, 2007
Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin useM Alan Brookhart, Amanda R Patrick, Sebastian Schneeweiss, et al.
Archives of Internal Medicine|February 29, 2012
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trialDaniel H Solomon, Maura D Iversen, Jerry Avorn, et al.
Diabetes|October 27, 2004
Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. populationMichael N Weedon, Katharine R Owen, Beverley Shields, et al.
Texas Heart Institute Journal|July 10, 2008
Devices in heart failure: potential methods for device-based monitoring of congestive heart failureShahzeb M Munir, Roberta C Bogaev, Ed Sobash, et al.
Anesthesiology|July 18, 2019
Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series AnalysisQi Chen, Hung-Lun Hsia, Robert Overman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2009
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitationsBrian D Bradbury, M Alan Brookhart, Wolfgang C Winkelmayer, et al.
Transfusion|May 1, 2007
Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferaseBahram Hosseini-Maaf, James A Letts, Mattias Persson, et al.
Pageof 39

Showing results (321-330 of 382) with videos related to

Sort By:
Pageof 39
Journal of the American Heart Association|April 25, 2020
Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor InitiationJennifer A Rymer, Katherine E Mues, Keri L Monda, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2018
Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United StatesAnne M Butler, Karynsa Cetin, Rohini K Hernandez, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Leveraging School Infection Data to Address Community COVID-19 Data GapsEba Moreda, Hedille Al-Dhalimy, Mary Ha, et al.
Archives of Internal Medicine|April 25, 2007
Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin useM Alan Brookhart, Amanda R Patrick, Sebastian Schneeweiss, et al.
Archives of Internal Medicine|February 29, 2012
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trialDaniel H Solomon, Maura D Iversen, Jerry Avorn, et al.
Diabetes|October 27, 2004
Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. populationMichael N Weedon, Katharine R Owen, Beverley Shields, et al.
Texas Heart Institute Journal|July 10, 2008
Devices in heart failure: potential methods for device-based monitoring of congestive heart failureShahzeb M Munir, Roberta C Bogaev, Ed Sobash, et al.
Anesthesiology|July 18, 2019
Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series AnalysisQi Chen, Hung-Lun Hsia, Robert Overman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2009
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitationsBrian D Bradbury, M Alan Brookhart, Wolfgang C Winkelmayer, et al.
Transfusion|May 1, 2007
Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferaseBahram Hosseini-Maaf, James A Letts, Mattias Persson, et al.
Pageof 39